Cost-effectiveness of warfarin: Trial versus ‘real-life’ stroke prevention in atrial fibrillation

Background and purpose: Previous cost-effectiveness analyses analyzed warfarin for stroke prevention in randomized trial settings. Given the complexities of warfarin treatment, cost-effectiveness should be examined within a real-world setting.

Preferences and utilities for the symptoms of moderate to severe allergic asthma.

Background: Moderate-to-severe allergic asthma has a substantial impact on patients’ quality of life (QOL). Despite care consistent with treatment guidelines, many patients with moderate-to-severe asthma still experience variability in asthma control, signaling an unmet need within this population.